Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Reexamination Certificate
2011-07-19
2011-07-19
Desai, Anand U (Department: 1652)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
C435S069100, C435S228000, C435S350000, C435S440000, C536S023200
Reexamination Certificate
active
07981655
ABSTRACT:
The document provides modified cytosine deaminases with increased solubility and high levels of DNA cytosine deaminase activity.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 6815194 (2004-11-01), Honjo et al.
Sawyer et al. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G, PLoS Biol. Sep. 2004;2(9):E275. Epub Jul. 20, 2004.
UniProt Accession No. Q694B7, DNA dC->dU editing enzyme APOBEC-3G, publication Oct. 11, 2004.
Whisstock et al. Quaterly Reviews of Biophysics, 2003, “Prediction of protein function from protein sequence and structure”, 36(3): 307-340.
Witkowski et al. Conversion of a beta-ketoacyl synthase to a malonyl decarboxylase by replacement of the active-site cysteine with glutamine, Biochemistry. Sep. 7, 1999;38(36):11643-50.
GenBank Accession No. AAH38808.1, dated Jan. 30, 2008, 3 pages.
GenBank Accession No. NM—001077845.1, dated Dec. 30, 2008, 2 pages.
GenBank Accession No. NM—001093784.1, dated May 23, 2007, 2 pages.
GenBank Accession No. NM—001097446.1, dated Feb. 19, 2009, 2 pages.
GenBank Accession No. NM—020661, dated Aug. 16, 2009, 4 pages.
GenBank Accession No. NM—021822, dated Jul. 26, 2009, 4 pages.
GenBank Accession No. NM—145298, dated Jul. 26, 2009, 5 pages.
GenBank Accession No. NP—004891.3, dated Aug. 3, 2008, 3 pages.
GenBank Accession No. NP—006780.1, dated Apr. 3, 2009, 2 pages.
GenBank Accession No. NP—055323.2, dated Mar. 15, 2009, 3 pages.
GenBank Accession No. NP13065712 , dated Aug. 16, 2009, 3 pages.
GenBank Accession No. NP—065712.1, dated Aug. 16, 2009, 3 pages.
GenBank Accession No. NP—068594.1, dated Jul. 26, 2009, 3 pages.
GenBank Accession No. NP—084531.1, dated Dec. 11, 2005, 2 pages.
GenBank Accession No. NP—660341, dated Jul. 26, 2009, 3 pages.
GenBank Accession No. NP—663745.1, dated Jul. 26, 2009, 3 pages.
Betts et al., “Cytidine Deaminase. The 2·3 Å Crystal Structure of an Enzyme: Transition-state Analog Complex,”J Mol Biol., 1994, 235(2):635-656.
Chelico et al., “APOBEC3G DNA deaminase acts processively 3′ --> 5′ on single-stranded DNA,”Nat Struct Mol Biol., 2006, 13(5):392-399.
Chen et al., “Extensive mutagenesis experiments corroborate a structural model for the DNA deaminase domain of APOBEC3G,”FEBS Letters, 2007, 581:4761-4766.
Chen et al., “Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G,”Nature, 2008, 452:116-121.
Clore et al., “Assignment of the Side-Chain1H and13C Resonances of Interleukin-1β Using Double- and Triple-Resonance Heteronuclear Three-Dimensional NMR Spectroscopy,”Biochemistry, 1990, 29(35):8172-8184.
Clubb et al., “A Constant-Time Three-Dimensional Triple-Resonance Pulse Scheme to Correlate Intraresidue1HN,15N, and13C' Chemical Shifts in15N-13C-Labeled Proteins,”J Magn Reson., 1992, 97:213-217.
Combet et al., “Geno3D: automatic comparative molecular modelling of protein,”Bioinformatics, 2002, 18(1):213-214.
Conticello et al., “DNA Deamination in Immunity: AID in the Context of Its APOBEC Relatives,”Adv Immunol., 2007, 94:37-73.
Cornilescu et al., “Protein backbone angle restraints from searching a database for chemical shift and sequence homology,”J Biomol NMR, 1999, 13:289-302.
Delaglio et al., “NMRPipe: A multidimensional spectral processing system based on UNIX pipes,”J Biomol NMR., 1995, 6(3):277-293.
Desmet et al., “The dead-end elimination theorem and its use in protein side-chain positioning,”Nature, 1992, 356:539-542.
Devany et al., “Solution NMR structure of the C-terminal domain of the human protein DEK,”Protein Sci., 2004, 13(8):2252-2259.
Goldstein, “Efficient Rotamer Elimination Applied to Protein Side-Chains and Related Spin Glasses,”Biophys J., 1994, 66:1335-1340.
Grzesiek et al., “Correlation of Backbone Amide and Aliphatic Side-Chain Resonances in13C/15N-Enriched Proteins by Isotopic Mixing of13C Magnetization,”J Magn Reson Series B, 1993, B101:114-119.
Guermeur et al., “Improved performance in protein secondary structure prediction by inhomogeneous score combination,”Bioinformatics, 1999, 15(5):413-421.
Haché et al., “The Retroviral Hypermutation Specificity of APOBEC3F and APOBEC3G Is Governed by the C-terminal DNA Cytosine 280(12): 10920-10924 Deaminase Domain,”J Biol Chem., 2005, 280(12):10920-10924.
Harjes et al., “An Extended Structure of the APOBEC3G Catalytic Domain suggests a Unique Holoenzyme Model,”J Mol Biol., 2009, 389:819-832.
Harris et al., “RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators,”Mol Cell, 2002, 10(5):1247-1253.
Herrmann et al., “Protein NMR structure determination with automated NOE-identification in the NOESY spectra using the new software ATNOS,”J Biomol NMR, 2002, 24:171-189.
Herrmann et al., “Protein NMR Structure Determination with Automated NOE Assignment Using the New Software CANDID and the Torsion Angle Dynamics Algorithm DYANA,”J Mol. Biol., 2002, 319(1):209-227.
Huthoff and Malim, “Cytidine deamination and resistance to retroviral infection: Towards a structural understanding of the APOBEC proteins,”Virology, 2005, 334(2):147-153.
Ikura et al., “A Novel Approach for Sequential Assignment of1H,13C, and15N Spectra of Larger Proteins: Heteronuclear Triple-Resonance Three-Dimensional NMR Spectroscopy. Application to Calmodulin,”Biochemistry, 1990, 29:4659-4667.
Iwatani et al., “Biochemical Activities of Highly Purified, Catalytically Active Human APOBEC3G: Correlation with Antiviral Effect,”J Virol., 2006, 80(12):5992-6002.
Jarmuz et al., “An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22,”Genomics, 2002, 79(3):285-296.
Johansson et al., “Crystal structure of the tetrameric cytidine deaminase fromBacillus subtilisat 2.0 A resolution,”Biochemistry, 2002, 41:2563-2570.
Jónsson et al., “Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins,”Nucl Acids Res., 2006, 34(19):5683-5694.
Kay et al., “Three-dimensional triple-resonance NMR spectroscopy of isotopically enriched proteins,”J Magn Reson., 1990, 89(3):496-514.
Ko et al., “Crystal Structure of Yeast Cytosine Deaminase,”J Biol Chem., 2003, 278(21):19111-19117.
Larue et al., “The artiodactylAPOBEC3innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals,”BMC Mol Biol., 2008, 9(104):1-20.
Larue et al., “Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins,”J Virol, 2009, 83(2):494-497.
Li et al., “Functional domains of APOBEC3G required for antiviral activity,”J Cell Biochem., 2004, 92(3):560-572.
Liddament et al., “APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 in Vivo,”Curr Biol., 2004, 14(15):1385-1391.
Losey et al., “Crystal structure ofStaphylococcus aureustRNA adenosine deaminase TadA in complex with RNA,”Nat Struct Mol Biol., 2006, 13(2):153-159.
Matsuo et al., “A Sensitive HN(CA)CO Experiment for Deuterated Proteins,”J Magn Reson., 1996, B 110:112-115.
Matsuo et al., “Increased Sensitivity in HNCA and HN(CO)CA Experiments by Selective CβDecoupling,”J Magn Reson., 1996, B 113:91-96.
Matsuo et al., “Use of Selective CαPulses for Improvement of HN(CA)CO-D and HN(COCA)NH-D Experiments,”J Magn Reson., 1996, B111:194-198.
Navarro et al., “Complementary function of the two catalytic domains of APOBEC3G,”Virology, 2005, 333(2):374-386.
Newman et al., “Antiviral function of APOBEC3G can be dissociated from cytidine
Harris Reuben S
Matsuo Hiroshi
Chowdhury Iqbal H
Desai Anand U
Fish & Richardson P.C.
Regents of the University of Minnesota
LandOfFree
Modified cytosine deaminases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified cytosine deaminases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified cytosine deaminases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2701616